Expert Pitch
Florida State University

FSU expert available for comment on COVID-19 Hate Crimes Bill

20-May-2021 4:50 PM EDT, by Florida State University

By: Anna Prentiss | Published: | 12:56 pm | SHARE: Share on FacebookTweet

President Joe Biden signed the COVID-19 Hate Crimes Act on Thursday, a law that will expedite the Justice Department’s review of hate crimes related to COVID-19 and designate an official at the department to oversee the effort, as well as issue new guidance to state and local law enforcement for online reporting.

The legislation is intended to target an increase in anti-Asian hate crimes that have come during the COVID-19 pandemic.

Florida State University’s Brendan Lantz is available to offer comments on the legislation and on hate crimes.

Brendan Lantz, assistant professor and director of Hate Crime Research and Policy Institute, College of Criminology and Criminal Justice 

As director of the Hate Crime Research and Policy Institute, Lantz researches hate crime, violence, victimization and co-offending.

“One of the primary purposes of this bill is to expedite review of COVID-19-related hate crimes, and these hate crimes are a real issue right now. Addressing them directly is important because these crimes have significant impacts for not only those who are directly victimized but the larger community as well. When someone is victimized for no other reason than that they are Asian (or perceived to be Asian), the impacts of that crime reverberate throughout the Asian community. If this additional review translates to additional resources and guidance for handling hate crimes, it has the potential to make a difference. 

The bill also provides guidance for establishing online reporting avenues for hate crimes. This may be particularly important because it is well-established that many hate crime victims are reluctant to report their victimization to the police. 

That said, hate crimes are a bit under the microscope right now, getting more attention because of the COVID-19-related increases that we are seeing, and they need to be addressed. But the reality is that many of the issues we are facing with the tracking of hate crimes have been serious issues since long before the pandemic began. So, we should be careful to view this legislation as one step toward addressing these issues. Moving forward, laws like this should be coupled with other legislation aimed at long-term changes in addressing and tracking hate crimes.” 



Filters close

Showing results

110 of 6075
Newswise: Don’t Let the Raging Virus Put Life in Jeopardy. Chula Recommends How to Build an Immunity for Your Heart Against Stress and Depression
Released: 28-Jul-2021 8:55 AM EDT
Don’t Let the Raging Virus Put Life in Jeopardy. Chula Recommends How to Build an Immunity for Your Heart Against Stress and Depression
Chulalongkorn University

Cumulative stress, denial, and chronic depression are the byproducts of the COVID-19 pandemic. The Center for Psychological Wellness, Chulalongkorn University recommends ways to cope by harnessing positive energy from our heart.

Newswise: Connect Chicago Initiative Expands Community COVID-19 Testing
Released: 27-Jul-2021 4:45 PM EDT
Connect Chicago Initiative Expands Community COVID-19 Testing
Rush University Medical Center

As COVID-19 cases rise in the U.S., Connect Chicago — new initiative between the Chicago Department of Public Health, Rush University Medical Center, and Esperanza Health Centers — is aiming to redouble testing efforts in Chicago communities that need it most.

Newswise: California State University to Implement COVID-19 Vaccination Requirement for Fall 2021 Term
Released: 27-Jul-2021 1:35 PM EDT
California State University to Implement COVID-19 Vaccination Requirement for Fall 2021 Term
California State University (CSU) Chancellor's Office

California State University to Implement COVID-19 Vaccination Requirement for Fall 2021 Term

Released: 27-Jul-2021 12:55 PM EDT
Behind the COVID-19 Diagnostic for Testing Hundreds of People at a Time
The Fannie and John Hertz Foundation

Hertz Fellow Cameron Myhrvold and colleagues are advancing research that started long before the pandemic.

Released: 27-Jul-2021 12:35 PM EDT
T cell response not critical for immune memory to SARS-CoV-2 or recovery from COVID-19
American Society for Microbiology (ASM)

New research conducted in monkeys reveals that T cells are not critical for the recovery of primates from acute COVID-19 infections.

Released: 27-Jul-2021 11:45 AM EDT
mRNA Vaccinations vs COVID-19 Risk in Teens – Vaccinations are Safer
Case Western Reserve University

Case Western Reserve University researchers have demonstrated that the risk for myocarditis/pericarditis (heart inflammation) among male teens (12-17) diagnosed with COVID-19 is nearly 6 times higher than their combined risk following first and second doses of an mRNA COVID-19 vaccination. The risk for myocarditis/pericarditis among girls (ages 12-17) is 21 times greater from COVID-19 than from vaccines.

Released: 27-Jul-2021 9:45 AM EDT
Twitter Study Tracks Early Days of COVID-19 Pandemic in U.S.
Binghamton University, State University of New York

Researchers at Binghamton University, State University of New York studied Twitter communications to understand the societal impact of COVID-19 in the United States during the early days of the pandemic.

Released: 27-Jul-2021 9:45 AM EDT
A First Report of COVID-19 Orbital Involvement Is Reported in the Journal of Craniofacial Surgery
Wolters Kluwer Health: Lippincott

A severe skin infection in the orbital area (around the eye) may represent an unusual complication of COVID-19, according to a patient report published in The Journal of Craniofacial Surgery. The journal is published in the Lippincott portfolio by Wolters Kluwer.

Newswise: “Baiya Vaccine” from Chula — a Testament of Thai Mastery — Coming this September
Released: 27-Jul-2021 8:55 AM EDT
“Baiya Vaccine” from Chula — a Testament of Thai Mastery — Coming this September
Chulalongkorn University

Chula Pharmacy prepares to test “Baiya Vaccine” a Thai vaccine against COVID–19 by “Baiya Phytofarm“, a Chula startup. The vaccines have been produced at the first plant in Asia that manufactures plant–based vaccines for humans. Clinical trials with volunteers and the research for the second–generation vaccine to fight the virus variants are to commence in September 2021.


Showing results

110 of 6075

close
12.36302